Evidence map›Paper›PMID 36939955›Full record

ArticleJournal of natural medicines2023

Ecological and pharmacognostical characteristics in Ephedra saxatilis in the Yarlung Zangbo River Valley of southeastern Tibetan Plateau, China.

Motoyasu Minami, Yukako Honda, Kaoru Ueno, Tetsuya Matsunaka, Junbo Wang, Liping Zhu, Akihito Takano, Takahisa Nakane

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Motoyasu MinamiCollege of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-Cho, Kasugai, Aichi, 487-8501, Japan. minami@isc.chubu.ac.jp.ORCID http://orcid.org/0000-0001-6680-2573
Yukako HondaCollege of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-Cho, Kasugai, Aichi, 487-8501, Japan.
Kaoru UenoCollege of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-Cho, Kasugai, Aichi, 487-8501, Japan.
Tetsuya MatsunakaInstitute of Nature and Environmental Technology, Kanazawa University, Wake O-24, Nomi, Ishikawa, 923-1224, Japan.
Junbo WangInstitute of Tibetan Plateau Research, Chinese Academy of Sciences, No.16, Lincui Road, Chaoyang District, Beijing, 100101, China.
Liping ZhuInstitute of Tibetan Plateau Research, Chinese Academy of Sciences, No.16, Lincui Road, Chaoyang District, Beijing, 100101, China.
Akihito TakanoShowa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo, 194-8543, Japan.
Takahisa NakaneShowa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo, 194-8543, Japan.

Funding

Advanced Research and Development Programs for Medical Innovation 22ak0101159h000The bilateral program-joint research projects between the National Natural Sciences Foundation of China and the Japan Society for the Promotion of Science 40701194The bilateral program-joint research projects between the National Natural Sciences Foundation of China and the Japan Society for the Promotion of Science 40871099
6 · The paper itself

Abstract

In the Yarlung Zangbo River Valley of the southeastern Tibetan Plateau, China (29°07'49.5"N, 92°41'11.0"E, 3256 m above sea level), we found an Ephedra saxatilis community in the xeric steppe with shrubland vegetation habitat of the broad alluvial plain of the river with soil having relatively higher water-soluble cation (Ca

Indexed as

EphedraChinaEphedrinePseudoephedrineRiversSoilTibetEphedrinePseudoephedrineSoilEphedra saxatilisEphedrine alkaloidSoil environmentTibet

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.